A group of investors including Marshall Wace, BVF Partners, Janus Henderson Investors and Logos Capital, led a $40m Series B funding round in Elektrofi, a biotechnology company. “This financing sets the stage for advancement of multiple lead programs to human trials, clinical validation of Elektrofi’s high concentration technology, and pipeline expansion in response to significant inbound platform interest. We view this as a foundational step on our journey to making a meaningful difference for patients and their loved ones,” Chase Coffman, Elektrofi CEO and Co-founder.